Abstract:Background: Luteolin (LUT) is a bioactive compound with several pharmacological activities including anticancer effect. Doxorubicin (DOX) is an anthracycline chemotherapeutic drug that have proven to be effective in treating various types of cancers. Polymeric micelles (PMs) containing biologically active materials have emerged as prospective dosage forms with high drug-loading, which can add therapeutic benefit to the poorly water-soluble compounds and novel chemical entities. PMs are effective in delivering several drugs, such as anticancer drugs, antifungal drugs, flavonoids and drugs targeting the brain. The aim of the current study is to develop PMs for LUT and DOX as a combined delivery system for cancer therapy. Methods: PMs were prepared using 2.5% of each of LUT and DOX with varying compositions of Poloxamer 188, Poloxamer 407, Vitamin E (TPGS), Poloxamer 123 and Gellucire 44/14 at room temperature. Particle size, polydispersity index, zeta potential, were achieved using Zetasizer Nano particle size analyzer and the sizes were further confirmed with transmission electron microscopy (TEM). Prepared PMs were further characterized using powder X-ray diffraction (PXRD) and fourier transform infrared spectroscopy (FTIR). An MTT assay was performed on breast cancer (MCF-7) cells and liver cancer (HepG2) cells to determine the cytotoxic effect of the different PMs formulations. Results: PMs were successfully developed and optimized using 74.3% Poloxamer 407 with 20.7% Vitamin E (TPGS), and 70% Poloxamer 407 with 25% Gellucire 44/14, respectively. The droplet size and polydispersity index were found to be 62.03 ± 3.99 nm, 91.96 ± 5.80 nm and 0.33 ± 0.05, 0.59± 0.03, respectively for PMs containing TPGS and Gellucire 44/14. Zeta potentials of the PMs containing TPGS and Gellucire 44/14 were recorded as -2.27 ±0.11mV and -7.78 ± 0.10 mV, respectively. The PMs showed a spherical structure with approximately 50-90 nm range evident by TEM analysis. The PXRD spectra of PMs powder presented the amorphization of LUT and DOX. The FTIR spectra of LUT-loaded and DOX-loaded PMs were identical, suggesting consistent PMs composition. The MTT assay showed that the representative combined drug loaded PMs treatment led to a reduction in the viability of MCF-7 and HepG2 cells compared to drug free PMs and pure LUT, DOX alone. Conclusions: PMs with LUT and DOX exhibited significant cytotoxic effects against breast and liver cancer cells and could thus be an important new pharmaceutical formulation to treat cancer.

Optimization and Formulation of Fucoxanthin-Loaded Microsphere (F-LM) Using Response Surface Methodology (RSM) and Analysis of Its Fucoxanthin Release Profile

Folic Acid Modified Cell Membrane Capsules Encapsulating Doxorubicin and Indocyanine Green for Highly Effective Combinational Therapy in Vivo.

Efficient delivery of fucoxanthin using alginate oligosaccharide-coated mesoporous silica

Preparation of 5-fluorouracilindomethacinpoly(L-lactide) microspheres using a novel supercritical fluid technique

Design optimization of Fucoidan-coating Cationic Liposomes for enhance Gemcitabine delivery

Process Optimization for the Preparation of Oligomycin-Loaded Folate-Conjugated Chitosan Nanoparticles As a Tumor-Targeted Drug Delivery System Using a Two-Level Factorial Design Method

Fabrication of Folate‐phytosterol‐carboxymethyl Cellulose Nanoparticles Derived from Plant Material As Carrier of Anticancer Drug

Characterization of Anti-Cancer Drug Materials Loaded Poly (3-Hydroxybutyrate-co-3-hydroxyhexanoate) Microspheres for Drug Delivery System in Biochemical Material System

Enhancing the fisetin efficacy through encapsulation with polymannose and nanotization for effective anticancer therapy towards breast cancer

Development of Polymeric Micelles for Combined Delivery of Luteolin and Doxorubicin for Cancer Therapy

Microencapsulation of alpha-mangostin into PLGA microspheres and optimization using response surface methodology intended for pulmonary delivery

Enhancing Anticancer Efficacy of Formononetin Microspheres via Microfluidic Fabrication

Development of a 5-Fluorouracil-loaded PLGA Microsphere Delivery System by a Solid-in-oil-in-hydrophilic Oil (s/o/ho) Novel Method for the Treatment of Tumors.

Stability and biological activity enhancement of fucoxanthin through encapsulation in alginate/chitosan nanoparticles

Development of a folate-modified curcumin loaded micelle delivery system for cancer targeting

Nanoemulsion-based Delivery Systems for Poorly Water-Soluble Bioactive Compounds: Influence of Formulation Parameters on Polymethoxyflavone Crystallization.

Biodegradable Interlayer-Crosslinked Polymer Micelles with Reduction Sensitivity for Non-Small Cell Lung Cancer Therapy.

Preparation and in Vitro Drug‐release Behavior of 5‐fluorouracil‐loaded Poly(hydroxybutyrate‐co‐hydroxyhexanoate) Nanoparticles and Microparticles

Study on Preparation and in Vitro Release of 5-Fluorouracil Loaded in PLGA Sustained-Release Microspheres

Preparation and Evaluation of Folic Acid Modified Succinylated Gelatin Micelles for Targeted Delivery of Doxorubicin

Polymer Microsphere for Water-Soluble Drug Delivery Via Carbon Dot-Stabilizing W/O Emulsion